Search Within

Benoit Rousseau

Formats
  1. Journal Article (23)
  2. Meeting Abstract (10)
  3. Editorial (5)
  4. Review (5)
  5. Correspondence (2)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Miscellaneous (1)
Groups
  1. Sloan Kettering Institute Postdocs (50)
  2. Department of Medicine (28)
  3. Gastrointestinal Oncology Service (28)
  4. Solid Tumor Oncology Division (28)
  5. Center for Pancreatic Cancer Research (24)
  6. GME, Medicine (15)

More Groups

People
  1. Luis Diaz (23)
  2. Andrea Cercek Hanjis (15)
  3. Guillermo Argiles Martinez (13)
  4. Michael Foote (13)
  5. Rona Yaeger (8)
  6. Neil Segal (7)

More People

Years
  1. 2025 (7)
  2. 2024 (7)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (7)
  6. 2020 (6)

More Years

Publications
  1. Annals of Oncology (8)
  2. Journal of Clinical Oncology (6)
  3. Digestive and Liver Disease (3)
  4. New England Journal of Medicine (3)
  5. Cancer Discovery (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. Oxford University Press (9)
  2. American Association for Cancer Research (6)
  3. American Society of Clinical Oncology (6)
  4. Elsevier Inc. (6)
  5. Cell Press (4)
  6. Nature Publishing Group (4)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High activity of nivolumab in patients with pathogenic exonucleasic domain POLE (edPOLE) mutated mismatch repair proficient (MMRp) advanced tumours
    Meeting Abstract

    Rousseau, B. J. C.; Bieche, I.; Pasmant, E.; Simmet, V.; Hamzaoui, N.; Masliah-Planchon, J.; Pouessel, D.; Bruyas, A.; Augereau, P.; Grob, J. J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of POLE/POLD1 variants as potential biomarkers for immune checkpoint inhibitor treatment outcomes
    Correspondence

    Rousseau, B.; Vidal, J.; Diaz, L. A. Jr
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition in colorectal cancer: Microsatellite instability and beyond
    Review

    Cohen, R.; Rousseau, B.; Vidal, J.; Colle, R.; Diaz, L. A. Jr; André, T.
    Targeted Oncology (2020)

    Fulltext@MSK | Save
  • Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
    Guidelines

    Cohen, R.; Vernerey, D.; Bellera, C.; Meurisse, A.; Henriques, J.; Paoletti, X.; Rousseau, B.; Alberts, S.; Aparicio, T.; Boukovinas, I.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Immune therapy for liver cancers
    Review

    Hilmi, M.; Vienot, A.; Rousseau, B.; Neuzillet, C.
    Cancers (2020)

    Fulltext@MSK | Save
  • Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: Current knowledge and future research directions
    Review

    Hilmi, M.; Neuzillet, C.; Calderaro, J.; Lafdil, F.; Pawlotsky, J. M.; Rousseau, B.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Clinicopathological and molecular criteria assessment for the screening of hypermutated proficient mismatch repair (pMMR) colorectal cancers (CRC) with exonucleasic domain POLE (edPOLE) mutations (mt)
    Meeting Abstract

    Rousseau, B. J. C.; Cohen, J.; Calderaro, J.; Dupuy, A.; Bourgoin, R.; Tournigand, C.; Baumgaertner, I.; Ropert, S.; Thirot Bidault, A.; Klotz, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Impact of the IDEA study on clinical practice for stage III colon cancer patients: A French GERCOR - FFCD - GI UNICANCER national survey
    Meeting Abstract

    Ouali, K.; Cohen, R.; Turpin, A.; Neuzillet, C.; Rousseau, B.; Garcia-Larnicol, M. L.; Tournigand, C.; Samalin, E.; Taieb, J.; André, T.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
    Guidelines

    Phelip, J. M.; Tougeron, D.; Léonard, D.; Benhaim, L.; Desolneux, G.; Dupré, A.; Michel, P.; Penna, C.; Tournigand, C.; Louvet, C.; more...
    Digestive and Liver Disease (2019)

    Fulltext@MSK | Save
  • Guidelines and tumor boards are required for solid organ recipients with de novo carcinoma
    Editorial

    Rousseau, B.; Guillemin, A.; Tournigand, C.
    Oncotarget (2019)

    Fulltext@MSK | Save